Comments
Here are answers to readers’ queries on the performance of their stock holdings.
I bought and averaged shares of Aurobindo Pharma and my average holding cost is ₹730. Now that the price has come down to ₹600 levels, can I buy and average at these levels or exit at loss? What is the outlook for this stock?
I have also bought YES Bank at ₹157. As it has come down, should I average?
K. Anand, Ramachandran
Aurobindo Pharma (₹602.3): Following a strong rally in 2014 and 2015, the stock of Aurobindo Pharma encountered resistance at ₹890 (price adjusted) in January 2016. Since then, it has been in a broad sideways consolidation phase in a wide range between ₹550 and ₹830. The upper boundary limited the upside in late 2018.
After testing resistance at ₹830 this April, the stock began to decline, witnessing selling interest. Since then, it has been in a medium-term downtrend within the broad sideways consolidation phase. While trending down, the stock had decisively breached the 50- and 200-day moving averages in April and continues to hover well below them. Short-term trend is also down for the stock. On Friday, the stock tumbled almost 4 per cent, accompanied by above-average volumes, breaking below a key support at ₹625.
The stock now tests the next support at ₹600. The daily relative strength index and price rate of change indicator show signs of positive divergence, indicating that trend reversal is likely. But a strong rise above ₹650 is needed for confirmation. The weekly indicators and oscillators continue to feature in the negative territory, backing the downtrend. Investors should, therefore, tread with caution.
A strong decline below ₹600 can drag the stock to ₹550, which is the lower boundary. The long-term support in the band between ₹530 and ₹550 can provide base for the stock. You can consider averaging the stockon declines with a stop-loss at ₹515. An upward reversal from the key long-term support band can take it higher to ₹650. A further rally above ₹650 can push the stock up to ₹700 and ₹725. To alter the medium-term downtrend, the stock needs to conclusively break above ₹725. Such a break can take the stock northwards to ₹770 and ₹800 levels. Next key resistances are at ₹830 and ₹850.
YES Bank (₹109.5): Since registering a new high at ₹404 in August 2018, the stock of YES Bank has been in a long-term downtrend. While trending down, it had decisively breached key supports at ₹300 and ₹175. Medium as well as short-term trends are down. The stock trades well below the 50- as well as 200-day moving averages. However, it began to trend up slightly after recording a 52-week low at ₹98.75 last week.
The daily relative strength index shows positive divergence, signalling that a trend reversal is on the cards. But a strong rally above ₹150 is needed for confirmation. Such a rally will also alter the short-term downtrend and take the stock up to ₹170. Next resistances are at ₹200 and ₹225.
To alter the medium-term downtrend, the stock needs to decisively move above ₹225 levels. Ensuing targets are ₹250 and ₹280 levels. On the other hand, a strong fall below ₹98 can drag the stock down to ₹90 and ₹85 levels.
You can wait for a trend reversal and consider averaging on a strong rally above the immediate resistance level of ₹130 with a stop-loss at ₹100.
Send your queries to techtrail@thehindu.co.in
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.